Management Team

Executive Team & Board of Directors

Roslyn Brandon
President & Chief Executive Officer – DVM, PhD, MBA

35 years experience; business executive, General Manager, CEO of UniQuest, MSI, Genetrax. Founding CEO of Immunexpress, directly responsible for driving capital, business and technology development to date. Raised over $40 million in high risk dilutive equity capital and non-dilutive grant funding over the last 10 years

Stefan Hendriks
Chief Financial Officer & Internal Legal Counsel – BCompt, MBA (Macq), MBA (IMD - Lausanne), CA (SA, AU)

40 years experience – finance, legal, investment banking and investment, corporate advisory and business/industry development (HWC (SA), Deloittes, Hill Samuel, Macquarie Bank, AGL Ltd, NEVI Group (Nor), Management Board Huon Aquaculture Ltd (AU) for 18 years). Financed, developed IKEA in Queensland, Australia. Senior management and Board roles in South Africa, Australia, Scandinavia and the Netherlands.

Richard Brandon
Chief Scientific Officer – BVSc (Hons), PhD, MBA

35 years experience as veterinary immunologist, molecular biologist, pathologist, animal and human healthcare R&D executive: Cornell, Sloan Kettering Cancer Research, University of Queensland, various private pathology laboratories, Genetrax, Plasvacc, BioNiche. Lead author on all Immunexpress patents; architect of IP strategy.

Roy Davis
Chief Medical Officer – MD PhD MHA
Roy Davis

30 years experience: clinical medicine (Neonatal, Pediatric Critical Care) and hospital administration. Clinical Assistant Professor, Department of Pediatrics, University of Washington. Consultant in health care standards and quality of care delivered.  CMO at Providence Alaska assisted in the implementation of MEWS and sepsis surveillance algorithms using the Microsoft Amalga platform across Providence Health & Services. Won a national Microsoft Healthcare innovation award for work with MEWS in 2012.

Leo McHugh
Vice President, Operations – BSc (Genetics), BSc (Comp Sci), PhD

15 years experience – statistics, epidemiological statistics, biostatistics, machine learning, management, re: complex biological information. VP – R&D and Director Bioinformatics (Immunexpress); Senior Computational Biologist, (Queensland Facility for Advanced Bioinformatics); Westmead Hospital (Sydney); NICTA (Australia’s ICT Research Centre of Excellence).

Thomas Yager
Director, Research & Development – BA, MS, PhD

30 years experience. University of Oregon, Weizmann Institute, Kings College London, Hospital for Sick Children (Toronto), and cross-appointment to Dept. Molecular/Medical Genetics, University of Toronto. Broad industry experience in biomarker discovery, development & validation of molecular diagnostic assays; multiple regulatory submissions in USA, Canada and Europe.

Kyle Serikawa
Senior Program Manager – BA (Biol.), PhD

kyle-photo-2

20 years experience. Postdoc (University of Washington) in genomic technologies focused on RNA and DNA analysis using high-throughput tools – oncology, infectious diseases, and immune disorders. Previous experience in Merck and Novo Nordisk A/S.